PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.98%
Revenue growth at 75-90% of MRVL's 10.96%. Bill Ackman would push for innovation or market expansion to catch up.
49.12%
Gross profit growth above 1.5x MRVL's 10.31%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
241.17%
Positive EBIT growth while MRVL is negative. John Neff might see a substantial edge in operational management.
241.17%
Positive operating income growth while MRVL is negative. John Neff might view this as a competitive edge in operations.
204.73%
Positive net income growth while MRVL is negative. John Neff might see a big relative performance advantage.
196.15%
Positive EPS growth while MRVL is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
196.15%
Positive diluted EPS growth while MRVL is negative. John Neff might view this as a strong relative advantage in controlling dilution.
9.26%
Slight or no buybacks while MRVL is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
9.26%
Slight or no buyback while MRVL is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
36.23%
OCF growth at 75-90% of MRVL's 41.93%. Bill Ackman would demand better working capital management or cost discipline.
31.32%
FCF growth under 50% of MRVL's 102.55%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
227.44%
10Y revenue/share CAGR above 1.5x MRVL's 82.85%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
227.44%
5Y revenue/share CAGR above 1.5x MRVL's 82.85%. David Dodd would look for consistent product or market expansions fueling outperformance.
227.44%
3Y revenue/share CAGR above 1.5x MRVL's 82.85%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
2003.06%
10Y OCF/share CAGR above 1.5x MRVL's 317.63%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
2003.06%
5Y OCF/share CAGR above 1.5x MRVL's 317.63%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
2003.06%
3Y OCF/share CAGR above 1.5x MRVL's 317.63%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
212.78%
Net income/share CAGR above 1.5x MRVL's 94.38% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
212.78%
5Y net income/share CAGR above 1.5x MRVL's 94.38%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
212.78%
3Y net income/share CAGR above 1.5x MRVL's 94.38%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
571.10%
Positive growth while MRVL is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
571.10%
Positive 5Y equity/share CAGR while MRVL is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
571.10%
Positive short-term equity growth while MRVL is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.10%
AR growth is negative/stable vs. MRVL's 19.44%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-29.26%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-0.78%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-2.92%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-0.44%
We’re deleveraging while MRVL stands at 33.63%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-0.70%
Our R&D shrinks while MRVL invests at 10.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
145.70%
SG&A growth well above MRVL's 3.38%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.